StatSure Diagnostic Systems (SSUR) Stock Overview

StatSure Diagnostic Systems, Inc. develops, manufactures, and markets rapid in-vitro assays for use in the detection of infectious diseases and other conditions in the United States and internationally. The company offers SURE CHECK HIV 1/2 and Clearview Complete HIV 1/ 2 tests, which are single-use diagnostic tests for visual detection of antibodies to HIV 1 and HIV 2. It also provides medical specimen collection devices. The company was founded in 1986 and is based in Brooklyn, New York.